Studies directed toward the synthesis of palau'amine and axinellamines A-D

The use of spiro [2.4]hepta-4,6-diene-1-methanol 7 as a general precursor for the synthesis of highly functionalized cyclopentyl rings is described. Diene 7 was converted to its silyl protected 4-nitrile derivative 24 in 46% overall yield. The cyclopropyl ring of 24 reacted with soft carbanionic nucleophiles to give ring opened homo-conjugate addition products 25a-h in 76-97% yield without loss of optical purity. The addition products could be further manipulated by selective mono-hydrogenation to give 1,2 substituted cyclopentenes 26a-e in 85-96% yield.

Diene 7 was used as a starting material for studies directed toward the synthesis of the stereochemically dense chloro-cyclopentyl core of palau'amine 1. Two advanced intermediates 50 and 72 were synthesized. Attempts to effect intramolecular chlorine transfer with 50 were unsuccessful. Attempted intramolecular chlorine transfer with 72 led, instead, to an oxygenated species resulting from oxygen radical trapping.

The enantioselective synthesis of the stereochemically dense chloro-cyclopenty l core of axinellamines A-D 2-5 starting from 7 is also described. The core is synthesized in 4.6% yield over 24 steps. Nakamura's radical dehalogenative hydroxylation is applied for the first time to a cyclopropyl carbonyl iodide to give the ring-opened product in 86% yield. Bolm's meso-anhydride desymmetrization is used to introduce asymmetry in a norbornene intermediate. The final step is a diastereoselective intermolecular chlorination using Barton's methodology to achieve chlorine transfer in 76% yield.

Biological Activity of Rhodium Metalloinsertors and the Design of Bifunctional Conjugates

The Barton laboratory has established that octahedral rhodium complexes bearing the sterically expansive 5,6-chrysene diimine ligand can target thermodynamically destabilized sites, such as base pair mismatches, in DNA with high affinity and selectivity. These complexes approach DNA from the minor groove, ejecting the mismatched base pairs from the duplex in a binding mode termed metalloinsertion. In recent years, we have shown that these metalloinsertor complexes also exhibit cytotoxicity preferentially in cancer cells that are deficient in the mismatch repair (MMR) machinery.

Here, we establish that a sensitive structure-activity relationship exists for rhodium metalloinsertors. We studied the relationship between the chemical structures of metalloinsertors and their effect on biological activity for ten complexes with similar DNA binding affinities, but wide variation in their lipophilicity. Drastic differences were observed in the selectivities of the complexes for MMR-deficient cells. Compounds with hydrophilic ligands were highly selective, exhibiting preferential cytotoxicity in MMR-deficient cells at low concentrations and short incubation periods, whereas complexes with lipophilic ligands displayed poor cell-selectivity. It was discovered that all of the complexes localized to the nucleus in concentrations sufficient for mismatch binding; however, highly lipophilic complexes also exhibited high mitochondrial uptake. Significantly, these results support the notion that mitochondrial DNA is not the desired target for our metalloinsertor complexes; instead, selectivity stems from targeting mismatches in genomic DNA.

We have also explored the potential for metalloinsertors to be developed into more complex structures with multiple functionalities that could either enhance their overall potency or impart mismatch selectivity onto other therapeutic cargo. We have constructed a family of bifunctional metalloinsertor conjugates incorporating cis-platinum, each unique in its chemical structure, DNA binding interactions, and biological activity. The study of these complexes in MMR-deficient cells has established that the cell-selective biological activity of rhodium metalloinsertors proceeds through a critical cellular pathway leading to necrosis.

We further explored the underlying mechanisms surrounding the biological response to mismatch recognition by metalloinsertors in the genome. Immunofluorescence assays of MMR-deficient and MMR-proficient cells revealed that a critical biomarker for DNA damage, phosphorylation of histone H2AX (γH2AX) rapidly accumulates in response to metalloinsertor treatment, signifying the induction of double strand breaks in the genome. Significantly, we have discovered that our metalloinsertor complexes selectively inhibit transcription in MMR-deficient cells, which may be a crucial checkpoint in the eventual breakdown of the cell via necrosis. Additionally, preliminary in vivo studies have revealed the capability of these compounds to traverse the complex environments of multicellular organisms and accumulate in MMR-deficient tumors. Our ever-increasing understanding of metalloinsertors, as well as the development of new generations of complexes both monofunctional and bifunctional, enables their continued progress into the clinic as promising new chemotherapeutic agents.